The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study.
Abstract
BACKGROUND: Sinking prebeta lipoprotein is a putative marker for elevated levels of lipoprotein (a). Although prospective data suggest that increased plasma lipoprotein (a) is an independent risk factor for coronary heart disease in men, no prospective studies are available in women. METHODS AND RESULTS: From 1968 through 1975, sinking prebeta lipoprotein was determined by paper electrophoresis in 3103 women Framingham Heart Study participants who were free of prevalent cardiovascular disease. A sinking prebeta lipoprotein band was detectable in 434 of the women (14%) studied. The median follow-up interval was approximately 12 years. Incident cardiovascular disease was associated with band presence using a proportional hazards model that included age, smoking, body mass index, systolic blood pressure, glucose intolerance, low- and high-density lipoprotein cholesterol, and ECG left ventricular hypertrophy. Multivariable adjusted relative risk estimates (with 95% confidence intervals) for outcomes in the band present versus absent groups were as follows: myocardial infarction (82 events), 2.37 (1.48 to 3.81); intermittent claudication (62 events), 1.94 (1.07 to 3.50); cerebrovascular disease (83 events), 1.88 (1.12 to 3.15); total coronary heart disease (174 events), 1.61 (1.13 to 2.29); and total cardiovascular disease (305 events), 1.44 (1.09 to 1.91). A subset analysis indicated that band presence was 50.9% sensitive and 95.4% specific for detecting plasma lipoprotein (a) levels of > 30 mg/dL, the threshold value linked to increased cardiovascular disease risk in men. CONCLUSIONS: Sinking prebeta lipoprotein was a valid surrogate for elevated lipoprotein (a) levels in Framingham Heart Study women. Band presence and, equivalently, elevated plasma lipoprotein (a), was a strong, independent predictor of myocardial infarction, intermittent claudication, and cerebrovascular disease. Confirmation of these findings in other longitudinal studies of women is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Self-citationAbell, L. L., Levy, B. B., Brodie, B. B., & Kendall, F. E. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50907-3 · Cited by 3,086
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
The mysteries of lipoprotein(a).
Utermann, G. (1989) · Science · doi:10.1126/science.2530631 · Cited by 1,257
The framingham offspring study. Design and preliminary data
Feinleib, M., Kannel, W. B., Garrison, R. J., McNamara, P. M., & Castelli, W. P. (1975) · Preventive Medicine · doi:10.1016/0091-7435(75)90037-7 · Cited by 930
Self-citationDahlen, G. H., Guyton, J. R., Attar, M., Farmer, J. A., Kautz, J. A., & Gotto, A. M. (1986) · Circulation · doi:10.1161/01.cir.74.4.758 · Cited by 911
Fibrinogen and Risk of Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1987) · JAMA · doi:10.1001/jama.1987.03400090067035 · Cited by 886
Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380180102027 · Cited by 783
Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 702
Lipoprotein Lp(a) and the risk for myocardial infarction
Kostner, G. M., Avogaro, P., Cazzolato, G., Marth, E., Bittolo-Bon, G., & Qunici, G. B. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90103-9 · Cited by 687
Armstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulze, F., Wieland, H., Kreuzer, H., & Seidel, D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90099-7 · Cited by 626
Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérum
Burstein, M., & Samaille, J. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90075-9 · Cited by 620
Seed, M., Hoppichler, F., Reaveley, D., McCarthy, S., Thompson, G. R., Boerwinkle, E., & Utermann, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222104 · Cited by 585
A potential basis for the thrombotic risks associated with lipoprotein(a)
Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 583
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510370051031 · Cited by 487
Self-citationLipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.240 · Cited by 461
Human plasma lipoprotein [a]. Structural properties.
Gaubatz, J. W., Heideman, C., Gotto, A. M., Morrisett, J. D., & Dahlen, G. H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32663-2 · Cited by 453
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H. J., & Beisiegel, U. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.579 · Cited by 446
CARLSON, L. A., HAMSTEN, A., & ASPLUND, A. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb01393.x · Cited by 443
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Sandkamp, M., Funke, H., Schulte, H., Köhler, E., & Assmann, G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.20 · Cited by 417
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
Eaton, D. L., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q. T., Miller, C. G., Lawn, R. M., & Scanu, A. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3224 · Cited by 416
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
MURAI, A., MIYAHARA, T., FUJIMOTO, N., MATSUDA, M., & KAMEYAMA, M. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90048-1 · Cited by 383
Jauhiainen, M., Koskinen, P., Ehnholm, C., Frick, M. H., Mänttäri, M., Manninen, V., & Huttunen, J. K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90007-p · Cited by 354
Genest, J., McNamara, J. R., Ordovas, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 331
Self-citationPopulation correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
FOLSOM, A., WU, K., DAVIS, C., CONLAN, M., SORLIE, P., & SZKLO, M. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90167-2 · Cited by 321
Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease
Berg, K., Dahlén, G., & Frick, M. H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00657.x · Cited by 316
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3847 · Cited by 285
Fless, G. M., Rolih, C. A., & Scanu, A. M. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90885-9 · Cited by 284
Atherogenesis in transgenic mice expressing human apolipoprotein(a)
Lawn, R. M., Wade, D. P., Hammer, R. E., Chiesa, G., Verstuyft, J. G., & Rubin, E. M. (1992) · Nature · doi:10.1038/360670a0 · Cited by 281
Radioimmunoassay of human plasma Lp(a) lipoprotein
Albers, J. J., Adolphson, J. L., & Hazzard, W. R. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41683-9 · Cited by 268
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
Gurakar, A., Hoeg, J. M., Kostner, G., Papadopoulos, N. M., & Brewer, H. B. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90041-3 · Cited by 261
Lipoprotein Lp(a). A risk factor for myocardial infarction.
Hoefler, G., Harnoncourt, F., Paschke, E., Mirtl, W., Pfeiffer, K. H., & Kostner, G. M. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.4.398 · Cited by 241
Apolipoproteins and ischaemic heart disease: implications for screening
Wald, N., Watt, H., Bailey, A., Johnson, M., Ledue, T. B., & Haddow, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90814-1 · Cited by 241
Teaching old dogmas new tricks
Brown, M. S., & Goldstein, J. L. (1987) · Nature · doi:10.1038/330113a0 · Cited by 238
Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesis
Mbewu, A. D., & Durrington, P. N. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90177-k · Cited by 228
Immunochemical quantification of human plasma Lp(a) lipoprotein
Albers, J. J., & Hazzard, W. R. (1974) · Lipids · doi:10.1007/bf02533209 · Cited by 217
Albers, J. J., Taggart, H. M., Applebaum-Bowden, D., Haffner, S., Chesnut, C. H., & Hazzard, W. R. (1984) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(84)90078-x · Cited by 187
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
Sigurdsson, G., Baldursdottir, A., Sigvaldason, H., Agnarsson, U., Thorgeirsson, G., & Sigfusson, N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91215-p · Cited by 187
Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.
Haberland, M. E., Fless, G. M., Scanu, A. M., & Fogelman, A. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50640-8 · Cited by 166
Sandholzer, C., Boerwinkle, E., Saha, N., Tong, M. C., & Utermann, G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115645 · Cited by 164
Soma, M. R., Osnago-Gadda, I., Paoletti, R., Fumagalli, R., Morrisett, J. D., Meschia, M., & Crosignani, P. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410120044006 · Cited by 159
Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease
Genest, J. J., Jenner, J. L., McNamara, J. R., Ordovás, J. M., Silberman, S. R., Wilson, P. W. F., & Schaefer, E. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90862-f · Cited by 154
Self-citationAlbers, J. J., Cabana, V. G., Warnick, G. R., & Hazzard, W. R. (1975) · Metabolism · doi:10.1016/0026-0495(75)90098-0 · Cited by 152
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a)
Vessby, B., Kostner, G. M., Lithell, H., & Thomis, J. A. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90053-3 · Cited by 145
Költringer, P., & Jürgens, G. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90065-6 · Cited by 142
Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.
Zioncheck, T. F., Powell, L. M., Rice, G. C., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115079 · Cited by 133
Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population
Heinrich, J., Sandkamp, M., Kokott, R., Schulte, H., & Assmann, G. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.11.1950 · Cited by 126
Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio, L., Chapman, M. J., Thillet, J., et al. (1993) · Blood · doi:10.1182/blood.v82.2.392.392 · Cited by 98
Simon, D. I., Fless, G. M., Scanu, A. M., & Loscalzo, J. (1991) · Biochemistry · doi:10.1021/bi00241a006 · Cited by 93
Lipoprotein(a) at birth, in blacks and whites
Rifai, N., HEISS, G. M., & Doetsch, K. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90271-h · Cited by 69
Studies of Lp-Lipoprotein as a Quantitative Genetic Trait
Harvie, N. R., & Schultz, J. S. (1970) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.66.1.99 · Cited by 65
Lipoprotein [Lp(a)] and peripheral vascular disease
TYRRELL, J., Cooke, T., Reilly, M. P., Colgan, M. P., Moore, D. J., Shanik, D. G., Bergin, C. J., & Feely, J. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00596.x · Cited by 58
Kark, J. D., Sandholzer, C., Friedlander, Y., & Utermann, G. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90124-d · Cited by 54
Miller, M., Bachorik, P., McCrindle, B., & Kwiterovich, P. (1993) · American Journal of Medicine · doi:10.1016/0002-9343(93)90113-4 · Cited by 53
Dahlén, G., Ericson, C., & Berg, K. (1978) · Clinical Genetics · doi:10.1111/j.1399-0004.1978.tb02058.x · Cited by 53
Leerink, C. B., Duif, P. F. C. C. M., Gimpel, J. A., Kortlandt, W., Bouma, B. N., & van Rijn, H. J. M. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656346 · Cited by 51
Craig, W. Y., Poulin, S., Forster, N. R., Neveux, L. M., Wald, N. J., & Ledue, T. B. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.4.550 · Cited by 50
SINKING PRE-BETA LIPOPROTEIN AND CORONARY HEART DISEASE IN JAPANESE-AMERICAN MEN IN HAWAII
Rhoads, G. G., Morton, N. E., Gulbrandsen, C. L., et al. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112631 · Cited by 48
Klausen, I. C., Gerdes, L. U., Meinertz, H., HANSEN, F. A., & Færgeman, O. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00768.x · Cited by 33
A rapid electrophoretic method for the detection of serum Lp(a) lipoprotein
Kawakami, K., Tsukada, A., Okubo, M., et al. (1989) · Clinica Chimica Acta · doi:10.1016/0009-8981(89)90037-5 · Cited by 28
Lack of effect of probucol on serum lipoprotein(a) levels
MAEDA, S., Okuno, M., Abe, A., et al. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90134-2 · Cited by 28
McNamara, J. R., Campos, H., Adolphson, J. L., Ordovás, J. M., Wilson, P. W. F., Albers, J. J., Usher, D. C., & Schaefer, E. J. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38321-8 · Cited by 25
Self-citationLp(a) lipoprotein in patients with arterial insufficiency of the lower extremities
Norrgård, Ö., Ängquist, K., & Dahlén, G. H. (1991) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(05)80510-9 · Cited by 18
Studies on an Additional Pre-β-Lipoprotein, Sinking Pre-β (SPB)
Lindén, L., Källberg, M., Gustafson, A., & Dahlén, G. (1976) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517609068018 · Cited by 9
Cited by
(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 658
Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Lipoproteins, nutrition, and heart disease
Schaefer, E. J. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.191 · Cited by 438
Self-citation
Metadata
- Authors
- Bostom, A. G., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Jenner, J. L., Ordovas, J. M., Schaefer, E. J., & Castelli, W. P.
- Venue
- Circulation
- Published
- 1994-10
- Volume
- 90
- Issue
- 4
- Pages
- 1688-1695
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1998030902
- Cited by
- 255
- References
- 66
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.